- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01413672
Preliminary Evaluation of CASTLE Barrier North American Prototype
Peristomal Skin Irritation: A Preliminary Evaluation of CASTLE Barrier North American Prototype
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
British Columbia
-
New Westminster, British Columbia, Canada, V3M 2T5
- Ostomy Care & Supply Centre
-
-
-
-
Arkansas
-
Hot Springs, Arkansas, United States, 71913
- Burke Pharmaceutical Research
-
-
Florida
-
Jacksonville, Florida, United States, 32246
- ET Nursing Services
-
-
Missouri
-
Fenton, Missouri, United States, 63026
- St. Louis Medical
-
Kansas City, Missouri, United States, 64119
- Restored Images
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
at least 18 years of age has colostomy or ileostomy current user of two-piece, flat, tape bordered barrier mild to moderate skin peristomal skin irritation community dwelling and cares for stoma independently at least 3 months post-operative provides informed consent
Exclusion Criteria:
presence of fistula on or near stoma prior participation in stoma care study within past 30 days pregnant or lactating (interview only) uses convex product, paste and/or rings known allergy to test barrier composition existing medical condition or therapy that might affect ability to participate or interpretation of study results
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
person with ostomy
Community dwelling subject with either colostomy or ileostomy and at least 3 months post-surgery.
|
Test barrier to be used in place of normal barrier.
Otherwise normal routine is followed
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Peristomal skin irritation
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Security
Time Frame: 30 days
|
wear time, lifting of barrier from skin, leakage
|
30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Richard Murahata, Ph.D., Hollister Incorporated
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 5075-O
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peristomal Skin Complication
-
Coloplast A/SCompletedPeristomal Skin ComplicationDenmark
-
Independent Nurse Consultants LLCConvaTec Inc.CompletedPeristomal Skin ComplicationUnited States
-
Coloplast A/SCompletedPeristomal Skin ComplicationNorway
-
Universidad de GranadaUniversity of Jaén; NOTALIV cosmética naturalCompletedIleostomy - Stoma | Peristomal Skin Complication | Colostomy StomaSpain
-
Istanbul UniversityCompletedSelf Efficacy | Nurse's Role | Peristomal Skin Complication | Patient ComplianceTurkey
-
Hollister IncorporatedTerminated
-
Johann Wolfgang Goethe University HospitalCompletedPeristomal Infection Rate | Postinterventional Bleeding | Postinterventional Mortality RateGermany
-
Malmö UniversityUniversity of CopenhagenUnknownOrthodontic Appliance Complication
-
Asst Melegnano e MartesanaEnrolling by invitationMortality | Nephrotoxicity | Respiratory Complication | Neurological Complication | Surgical Complication | Metabolic Complication | Cardiovascular ComplicationItaly
-
National Cheng Kung UniversityUnknownThe Patients Who Receive Percutaneous Endoscopic Gastrostomy | Peristomal Wound Infection After the Operation of PEG | Prophylactic Antibiotics Before PEGTaiwan
Clinical Trials on Use of CASTLE barrier
-
Hollister IncorporatedTerminated
-
Kenvue Brands LLCCompletedAcne VulgarisUnited States
-
Karadeniz Technical UniversityCompletedDiaper Dermatitis HealingTurkey
-
University of PennsylvaniaPfizer; Pennsylvania Department of Health; Dickinson CollegeCompleted
-
Centre Leon BerardMinistry of Health, FranceCompletedColorectal CancerFrance
-
King's College LondonCharite University, Berlin, Germany; University Hospital, Bonn; Institut Curie; Levantine UKRecruitingAllergy;Food | Food Allergy Peanut | Pathways and Sources of ExposureUnited Kingdom
-
Postgraduate Institute of Dental Sciences RohtakCompletedApical Periodontitis
-
University College CorkCompletedEczema | Food Allergy | Eczema, Infantile | Eczema Atopic DermatitisIreland
-
ScotiadermThe Salvation Army Toronto Grace Health CentreNot yet recruitingFecal Incontinence | Incontinence Associated Dermatitis | Moisture Associated Skin Damage
-
Boston Children's HospitalUnknownPediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)United States